1. Home
  2. RYTM vs VFC Comparison

RYTM vs VFC Comparison

Compare RYTM & VFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • VFC
  • Stock Information
  • Founded
  • RYTM 2008
  • VFC 1899
  • Country
  • RYTM United States
  • VFC United States
  • Employees
  • RYTM N/A
  • VFC N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • VFC Apparel
  • Sector
  • RYTM Health Care
  • VFC Consumer Discretionary
  • Exchange
  • RYTM Nasdaq
  • VFC Nasdaq
  • Market Cap
  • RYTM 5.9B
  • VFC 4.9B
  • IPO Year
  • RYTM 2017
  • VFC N/A
  • Fundamental
  • Price
  • RYTM $97.61
  • VFC $13.08
  • Analyst Decision
  • RYTM Strong Buy
  • VFC Buy
  • Analyst Count
  • RYTM 13
  • VFC 19
  • Target Price
  • RYTM $101.92
  • VFC $16.00
  • AVG Volume (30 Days)
  • RYTM 578.8K
  • VFC 10.5M
  • Earning Date
  • RYTM 08-05-2025
  • VFC 07-30-2025
  • Dividend Yield
  • RYTM N/A
  • VFC 2.75%
  • EPS Growth
  • RYTM N/A
  • VFC N/A
  • EPS
  • RYTM N/A
  • VFC N/A
  • Revenue
  • RYTM $156,287,000.00
  • VFC $9,496,297,000.00
  • Revenue This Year
  • RYTM $37.86
  • VFC $1.09
  • Revenue Next Year
  • RYTM $72.72
  • VFC $3.30
  • P/E Ratio
  • RYTM N/A
  • VFC N/A
  • Revenue Growth
  • RYTM 53.55
  • VFC N/A
  • 52 Week Low
  • RYTM $43.57
  • VFC $9.41
  • 52 Week High
  • RYTM $99.04
  • VFC $29.02
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 73.48
  • VFC 57.69
  • Support Level
  • RYTM $95.30
  • VFC $11.65
  • Resistance Level
  • RYTM $99.04
  • VFC $13.11
  • Average True Range (ATR)
  • RYTM 3.21
  • VFC 0.71
  • MACD
  • RYTM 0.20
  • VFC 0.10
  • Stochastic Oscillator
  • RYTM 90.50
  • VFC 45.80

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About VFC V.F. Corporation

VF designs, produces, and distributes branded apparel, footwear, and accessories. Its apparel categories are active, outdoor, and work. Its portfolio of 11 brands includes Vans, The North Face, Timberland, Altra, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. Tracing its roots to 1899, the company has evolved through many brand acquisitions and dispositions.

Share on Social Networks: